Not long ago, when a dog was diagnosed with lymphoma, one of the most common forms of canine cancer, pet guardians had little reason to hope for a cure. With success rates of less than 2% and remission times lasting on average just over 12 months, current chemotherapy protocols have not been able to offer much promise of long term success. But, a new method of treating dogs with lymphoma is changing all of that.

Doctors at North Carolina State University’s (NCSU) Veterinary Teaching Hospital are now using bone marrow transplants (BMT) to treat canine patients with lymphoma – a new application of an existing technology responsible for saving the lives of thousands of humans each year. It was the impressive success rate of NCSU’s Bone Marrow Transplant Unit that convinced Kristie and Johnny Sullens that a BMT was the best chance of saving their dog Angel’s life.

After all, she was a vibrant, 5 year old Carolina Yellow Dog with years of life left to live, and an adoring brother named Romeo that couldn’t stand to be apart from her for even a minute.

From the moment she showed up on their doorstep as a stray puppy, Angel had been their child in every sense, and it was unbearable to imagine their family without her. How could they not do everything possible to attempt a real cure for her cancer.

You can download K9 Magazine's full report in to canine lymphoma at this link.